Istaroxime, a first in class new chemical entity exhibiting SERCA-2 activation and Na–K-ATPase inhibition: a new promising treatment for acute heart failure syndromes?-Reference-Cited by-同舟云学术

Istaroxime, a first in class new chemical entity exhibiting SERCA-2 activation and Na–K-ATPase inhibition: a new promising treatment for acute heart failure syndromes?

Published:2009-02-24 Issue:4 Volume:14 Page:277-287
ISSN:1382-4147
Container-title:Heart Failure Reviews
language:en
Short-container-title:Heart Fail Rev

Author:

Khan Hashim,Metra Marco,Blair John E. A.,Vogel Mark,Harinstein Matthew E.,Filippatos Gerasimos S.,Sabbah Hani N.,Porchet Herve,Valentini Giovanni,Gheorghiade Mihai

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10741-009-9136-z.pdf

Reference25 articles.

1. Lloyd-Jones D et al (2009) Heart disease and stroke statistics—2009 update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119(3):e21–e181. doi: 10.1161/CIRCULATIONAHA.108.191261

2. Lloyd-Jones DM et al (2002) Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 106(24):3068–3072. doi: 10.1161/01.CIR.0000039105.49749.6F

3. Gheorghiade M et al (2005) Acute heart failure syndromes: current state and framework for future research. Circulation 112(25):3958–3968. doi: 10.1161/CIRCULATIONAHA.105.590091

4. Gheorghiade M et al (2006) Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. J Am Med Assoc 296(18):2217–2226. doi: 10.1001/jama.296.18.2217

5. Elkayam U et al (2007) Use and impact of inotropes and vasodilator therapy in hospitalized patients with severe heart failure. Am Heart J 153(1):98–104. doi: 10.1016/j.ahj.2006.09.005

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review of Contemporary and Future Pharmacotherapy for Chronic Heart Failure in Children;Children;2024-07-16

2. Small molecule regulators of microRNAs identified by high-throughput screen coupled with high-throughput sequencing;Nature Communications;2023-11-21

3. Current understanding of structural and molecular changes in diabetic cardiomyopathy;Life Sciences;2023-11

4. 6-Nitrodopamine Is the Most Potent Endogenous Positive Inotropic Agent in the Isolated Rat Heart;Life;2023-10-04

5. Positive Allosteric Modulators of SERCA Pump Restore Dendritic Spines and Rescue Long-Term Potentiation Defects in Alzheimer’s Disease Mouse Model;International Journal of Molecular Sciences;2023-09-12